Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04157985
Title Evaluation of the Length of Treatment With PD-1/PD-L1 Inhibitors in Patients With Advanced Solid Tumors
Recruitment Recruiting
Gender both
Phase Phase III
Variant Requirements No
Sponsors Antoinette J Wozniak
Indications

Advanced Solid Tumor

Therapies

Nivolumab

Ipilimumab

Pembrolizumab

Atezolizumab

Age Groups: senior | adult
Covered Countries USA


No variant requirements are available.